Mayne Pharma shares surge on $407 mln takeover offer from Gedeon Richter
In short
The market responded swiftly after Gedeon Richter tabled a buyout proposal valued at $407 million. Equity in Mayne Pharma jumped substantially in the wake of the acquisition approach. The offer represents a significant takeover attempt targeting the pharmaceutical company.
Key points
- Mayne Pharma is currently evaluating a significant buyout offer from suitor Gedeon Richte…: Mayne Pharma is currently evaluating a significant buyout offer from suitor Gedeon Richter.
- Investor enthusiasm drove a sharp rally in the target company's publicly traded shares.: Investor enthusiasm drove a sharp rally in the target company's publicly traded shares.
- The transaction would value the pharmaceutical business at a total of $407 million.: The transaction would value the pharmaceutical business at a total of $407 million.